Upvote
Downvote
Senior Accountant / Sec Reporting Analyst
Share Job
- Suggest Revision
$107,000 - $148,000 a year
Full-time
- Adicet Bio, Inc. is a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer.
- Adicet is advancing a pipeline of "off-the-shelf" gamma delta T cells, engineered with chimeric antigen receptors (CARs) and adaptors (CAds), to enhance selective tumor targeting and facilitate innate and adaptive anti-tumor immune response for durable activity in patients.
- The SEC Reporting Analyst/senior accountant is an integral part of a growing accounting team, reporting directly to the Senior Manager, SEC Reporting and SOX Compliance.
- In addition, this person will play an active role in stock administration, interacting with our third party stock plan administrator regarding equity activity (grants, exercises, RSU releases, ESPP) as well as engage with our third party consultants on stock based compensation expense.
- Interact with our third party stock plan administrator regarding equity activity and updating Equity Edge Online.
Active Job
Updated 6 days agoSimilar Job
Relevance
Active